Alan Ashworth
Director/Board Member at CYTOMX THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
Alan Ashworth is the founder of Tango Therapeutics Sub, Inc. (2017) and Tango Therapeutics, Inc. (2017).
He currently holds positions as an Independent Director at CytomX Therapeutics, Inc. (since 2021), and as a Member at the Academy of Medical Sciences, the European Molecular Biology Organization, the UCSF Helen Diller Family Comprehensive Cancer Center, and as an Advisor at Phoenix Molecular Designs Ltd., Catalio Capital Management LP, and Ambagon Therapeutics, Inc. Dr. Ashworth's former positions include Chief Executive Officer at The Institute of Cancer Research, Director at the American Association for Cancer Research, and Director at Breakthrough Breast Cancer.
Dr. Ashworth's education includes an undergraduate degree from Imperial College London and a doctorate from University College London.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-18 | 0 ( -.--% ) | - $ | 2024-03-30 |
Alan Ashworth active positions
Companies | Position | Start |
---|---|---|
CYTOMX THERAPEUTICS, INC. | Director/Board Member | 2021-09-28 |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Corporate Officer/Principal | - |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Consultant / Advisor | - |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Consultant / Advisor | - |
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The private company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | President | - |
Former positions of Alan Ashworth
Companies | Position | End |
---|---|---|
Breakthrough Breast Cancer
Breakthrough Breast Cancer Miscellaneous Commercial ServicesCommercial Services Part of Breast Cancer Campaign, Breakthrough Breast Cancer provides research and development services for breast cancer. The private company is based in London, UK. The British company was founded in 1993. Breakthrough Breast Cancer was acquired by Breast Cancer Campaign on June 16, 2015. | Director/Board Member | - |
The Institute of Cancer Research
The Institute of Cancer Research Pharmaceuticals: MajorHealth Technology The Institute of Cancer Research studies the interplay of genes, proteins, and biological processes that drive the development, growth, and spread of cancers. The private company is based in London, UK. The British company focuses on identifying new treatment targets. | Chief Executive Officer | - |
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░ | - |
Training of Alan Ashworth
Imperial College London | Undergraduate Degree |
University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CYTOMX THERAPEUTICS, INC. | Health Technology |
TANGO THERAPEUTICS, INC. | Health Technology |
Private companies | 10 |
---|---|
Academy of Medical Sciences
Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK. | Commercial Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
European Molecular Biology Organization | |
Breakthrough Breast Cancer
Breakthrough Breast Cancer Miscellaneous Commercial ServicesCommercial Services Part of Breast Cancer Campaign, Breakthrough Breast Cancer provides research and development services for breast cancer. The private company is based in London, UK. The British company was founded in 1993. Breakthrough Breast Cancer was acquired by Breast Cancer Campaign on June 16, 2015. | Commercial Services |
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center Other Consumer ServicesConsumer Services Part of University of California, UCSF Helen Diller Family Comprehensive Cancer Center is a research, teaching, and patient care center that aims to deliver breakthroughs in cancer treatment. The private company is based in San Francisco, CA. The center offers social workers who provide support, problem-solving, and help accessing cancer-related resources to patients. | Consumer Services |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Phoenix Molecular Designs Ltd.
Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Commercial Services |
The Institute of Cancer Research
The Institute of Cancer Research Pharmaceuticals: MajorHealth Technology The Institute of Cancer Research studies the interplay of genes, proteins, and biological processes that drive the development, growth, and spread of cancers. The private company is based in London, UK. The British company focuses on identifying new treatment targets. | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Alan Ashworth